Patent ID: 7332280

Claim:
A method for classifying a patient having diffuse large B-cell lymphoma (DLBCL), the method comprising: measuring expression of a plurality of genes in a tumor sample from the patient to produce measured expression values; normalizing said measured expression values to produce normalized expression values; correlating said normalized expression values to normalized reference expression values obtained for said plurality of genes from DLBCL patients grouped into survival groups; and classifying the patient into one of said survival groups based upon weighed predictor Z in formula: Z= ( A×LMO 2)+( B×BCL 6)+( C×FN 1)+( D×CCND 2)+( E×SCYA 3)+( F×BCL 2) wherein A is −0.03, B is −0.2, C is −0.2, D is 0.03, E is 0.2, and F is 0.6 and wherein LMO2, BCL6, FN1, CCND2, SCYA3 and BCL2 are log base 2 of normalized expression values for genes LMO2, BCL6, FN1, CCND2, SCYA3 and BCL2, respectively.